Loading people...
Jason Robart is a Managing Partner at Seae Ventures, a venture capital firm. He is responsible for leading investment strategies and identifying high-potential early-stage companies, primarily in healthcare and technology.
Jason Robart invests in early-stage companies, with a primary focus on healthcare, life sciences, and health technology sectors. He seeks disruptive solutions that improve patient care, operational efficiency, and advance medical research.
Jason Robart works as a Managing Partner at Seae Ventures, a venture capital firm.
Jason Robart serves as a distinguished Managing Partner at Seae Ventures, a prominent venture capital firm dedicated to fostering innovation across critical sectors. In his pivotal role, Jason is instrumental in shaping the firm's investment strategy, identifying high-potential early-stage companies, and guiding them through crucial growth phases. His leadership at Seae Ventures is characterized by a deep commitment to uncovering disruptive technologies and business models that promise significant impact and returns.
At Seae Ventures, Jason Robart primarily focuses on investments within the healthcare, life sciences, and health technology sectors. He seeks out companies that are developing groundbreaking solutions to complex challenges, from improving patient care and operational efficiency to advancing medical research and digital health platforms. Jason is particularly interested in ventures that demonstrate strong market potential, innovative intellectual property, and a clear path to commercialization. His investment philosophy emphasizes long-term partnerships with visionary founders, providing not just capital but also strategic guidance, operational expertise, and access to an extensive industry network.
Jason's career background is marked by a robust blend of operational leadership and extensive experience in venture capital. Prior to his tenure at Seae Ventures, he held significant roles where he was responsible for driving growth and strategic initiatives within established healthcare organizations. This hands-on operational experience provides him with a unique perspective, enabling him to thoroughly evaluate the practical viability and scalability of new ventures. His earlier career also included positions within investment firms, where he honed his skills in deal sourcing, due diligence, and portfolio management across various technology and life science domains. This diverse background equips him with a comprehensive understanding of both the entrepreneurial journey and the intricacies of the investment landscape.
Throughout his career, Jason Robart has built a reputation for identifying and nurturing successful ventures that have gone on to achieve significant milestones. While specific investment details are often confidential, his track record reflects a keen eye for innovation and a strategic approach to value creation. He is known for his ability to forge strong relationships with founders, offering mentorship and support that extends beyond financial backing. Jason's contributions are vital to Seae Ventures' mission of empowering the next generation of industry leaders and driving meaningful progress in the sectors they serve. His expertise ensures that Seae Ventures remains at the forefront of investing in the future of healthcare and technology.
Jason Robart is the Co-founder and Managing Partner at Seae Ventures, an early-stage venture capital firm based in Boston, Massachusetts. Prior to launching the investment firm in 2019, he served as the Chief Strategy Officer at Blue Cross Blue Shield of Massachusetts and was the President and Chief Executive Officer of its corporate venture capital arm, Zaffre Investments. He previously held executive leadership positions at Health Dialog and earned a bachelor's degree in political science from Middlebury College. At Seae Ventures, Robart co-led the successful closing of a $107 million inaugural fund in 2022 and recently announced a $150 million close for the firm's third fund to expand its portfolio of over twenty startups. His current investment strategy focuses on funding historically underrepresented founders who are building early-stage healthcare, healthtech, and financial technology companies.
